News & Updates

Risk of myasthenia gravis onset highest in first month after statin initiation

14 Dec 2024 by

A study investigating the association between the risk of myasthenia gravis (MG) and statin therapy found the risk of onset in patients with no prior history of MG and the risk of exacerbation among patients with pre-existing MG were the highest in the first month after initiating statins.

Risk of myasthenia gravis onset highest in first month after statin initiation

14 Dec 2024

EVT outcomes poorer in ischaemic stroke patients ≥80 years old

10 Dec 2024 by

Outcomes after endovascular thrombectomy (EVT) in patients ≥80 years old were significantly worse than those in their younger counterparts, a Hong Kong stroke centre study has found.

EVT outcomes poorer in ischaemic stroke patients ≥80 years old

10 Dec 2024

CV risk and obesity associated with reduced brain volume earlier in males than females

10 Dec 2024 by

The detrimental influence of cardiovascular (CV) risk and obesity on grey matter volume impacts males a decade earlier than females, a recent UK study has found.

CV risk and obesity associated with reduced brain volume earlier in males than females

10 Dec 2024

Chinese medicine herbal compound of no benefit in intracerebral haemorrhage

09 Dec 2024

In the treatment of patients with moderate to severe intracerebral haemorrhage, the traditional Chinese medicine herbal compound FYTF-919 has no significant effect on functional recovery, survival, and health-related quality of life, as shown in a study.

Chinese medicine herbal compound of no benefit in intracerebral haemorrhage

09 Dec 2024

AAIC 2024: Early Alzheimer’s disease patients reap sustained benefits from long-term lecanemab treatment

09 Dec 2024 by

At the Alzheimer’s Association International Conference (AAIC) 2024 held in Philadelphia, US, researchers presented latest findings on the use of the dual-acting, anti–amyloid beta (Aβ) protofibril antibody, lecanemab, for treatment of early Alzheimer’s disease (AD). Topics covered included the paradoxical brain volume changes associated with anti-amyloid immunotherapy and the 3-year clinical efficacy results of continuous lecanemab treatment from the phase III Clarity AD study.

AAIC 2024: Early Alzheimer’s disease patients reap sustained benefits from long-term lecanemab treatment

09 Dec 2024

Common heart medication shows therapeutic potential in Huntington disease

08 Dec 2024 by

New research suggests that the use of beta-blockers may help delay the onset of motor symptoms in people with early-stage Huntington disease, as well as reduce the worsening of symptoms in those already experiencing movement issues.

Common heart medication shows therapeutic potential in Huntington disease

08 Dec 2024

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

05 Dec 2024 by

For individuals with type 2 diabetes mellitus (T2DM), the earlier the age at diagnosis, the higher the likelihood of subsequent coronary heart disease (CHD), stroke, cancer, and all-cause death, as shown in a study.

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

05 Dec 2024

Exercise linked to lower falls risk among people with cognitive frailty

05 Dec 2024

People with cognitive frailty are at increased risk of falls, but the good news is that exercise helps improve physical function and reduce this risk, according to a study.

Exercise linked to lower falls risk among people with cognitive frailty

05 Dec 2024

Low BMD predicts death, infections in stroke patients

04 Dec 2024

Stroke patients who have low bone mineral density (BMD), particularly in the spine and femur, are at greater risk of mortality and urinary tract infection (UTI), reveals a study.

Low BMD predicts death, infections in stroke patients

04 Dec 2024

People with epilepsy face high burden of psychiatric comorbidities

03 Dec 2024

Psychiatric disorders such as anxiety, depression, schizophrenia, autism spectrum disorder, and alcohol dependence, among others, are more prevalent among people with epilepsy than among those who do not have the neurological condition, according to the results of a meta-analysis.

People with epilepsy face high burden of psychiatric comorbidities

03 Dec 2024

News & Updates

Filter by Specialty:

Specialty:

Risk of myasthenia gravis onset highest in first month after statin initiation

Risk of myasthenia gravis onset highest in first month after statin initiation

EVT outcomes poorer in ischaemic stroke patients ≥80 years old

EVT outcomes poorer in ischaemic stroke patients ≥80 years old

CV risk and obesity associated with reduced brain volume earlier in males than females

CV risk and obesity associated with reduced brain volume earlier in males than females

Chinese medicine herbal compound of no benefit in intracerebral haemorrhage

Chinese medicine herbal compound of no benefit in intracerebral haemorrhage

AAIC 2024: Early Alzheimer’s disease patients reap sustained benefits from long-term lecanemab treatment

AAIC 2024: Early Alzheimer’s disease patients reap sustained benefits from long-term lecanemab treatment

Common heart medication shows therapeutic potential in Huntington disease

Common heart medication shows therapeutic potential in Huntington disease

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

Exercise linked to lower falls risk among people with cognitive frailty

Exercise linked to lower falls risk among people with cognitive frailty

Low BMD predicts death, infections in stroke patients

Low BMD predicts death, infections in stroke patients

People with epilepsy face high burden of psychiatric comorbidities

People with epilepsy face high burden of psychiatric comorbidities